Next Article in Journal
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
Next Article in Special Issue
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
Previous Article in Journal
Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
Previous Article in Special Issue
The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
 
 
Review

Article Versions Notes

Cancers 2022, 14(8), 2000; https://doi.org/10.3390/cancers14082000
Action Date Notes Link
article pdf uploaded. 14 April 2022 18:34 CEST Version of Record https://www.mdpi.com/2072-6694/14/8/2000/pdf-vor
article xml file uploaded 15 April 2022 07:41 CEST Original file -
article xml uploaded. 15 April 2022 07:41 CEST Update -
article pdf uploaded. 15 April 2022 07:41 CEST Updated version of record https://www.mdpi.com/2072-6694/14/8/2000/pdf-vor
article html file updated 15 April 2022 07:43 CEST Original file -
article pdf uploaded. 6 May 2022 13:42 CEST Updated version of record https://www.mdpi.com/2072-6694/14/8/2000/pdf
article xml uploaded. 6 May 2022 13:42 CEST Update https://www.mdpi.com/2072-6694/14/8/2000/xml
article html file updated 6 May 2022 13:43 CEST Update -
article html file updated 2 August 2022 19:03 CEST Update https://www.mdpi.com/2072-6694/14/8/2000/html
Back to TopTop